AI Article Synopsis

  • The study aims to evaluate the effects of isoflavone supplementation on menopausal symptoms and ovarian hormones in postmenopausal women, as previous research has produced mixed results.
  • A systematic review and meta-analysis of 11 randomized controlled trials found that isoflavones significantly increased estradiol levels and improved the Kupperman index but did not significantly impact hot flashes or certain hormonal levels.
  • The authors caution that while the findings are promising, high variability among studies suggests the need for larger trials to confirm the results.

Article Abstract

Background/objectives: Complementary and alternative medicines can be used to alleviate climacteric symptoms that significantly affect the quality of life of postmenopausal women. Isoflavones are the most common plant-based therapies for postmenopausal changes, but the results of previous studies have been controversial.

Materials/methods: To investigate whether isoflavones would affect menopausal symptoms as well as ovarian hormones, we performed a systematic review and meta-analysis. The PubMed and EMBASE databases were used to perform the systematic search. Included studies were limited to randomized controlled trials (RCTs) assessing the impact of isoflavone supplementation on menopausal symptoms.

Results: Eleven studies were included for the final quantitative assessment. Isoflavone intervention was varied between 49.3 and 135 mg of isoflavones per day for 12 wk-2 yrs. The meta-analysis showed that supplementation of isoflavones significantly increased the estradiol levels (standardized mean difference [SMD] = 0.615, = 0.035) and Kupperman index (SMD = 3.121, = 0.003) but had no significant effect on hot flashes, follicle-stimulating hormone, and luteinizing hormone. However, both estradiol and the Kupperman index showed significant heterogeneity among studies (I = 94.7%, < 0.001 and I = 98.1%, < 0.001, respectively).

Conclusions: Although the results showed a significant SMD in estradiol and the Kupperman index, the results should be interpreted with caution due to the high heterogeneity. Further validation with a larger RCT will be necessary. Overall, isoflavone supplementation has distinct effects on the climacteric symptoms and hormonal changes in postmenopausal women.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127519PMC
http://dx.doi.org/10.4162/nrp.2022.16.S1.S147DOI Listing

Publication Analysis

Top Keywords

isoflavone supplementation
12
supplementation menopausal
8
menopausal symptoms
8
systematic review
8
review meta-analysis
8
randomized controlled
8
controlled trials
8
climacteric symptoms
8
postmenopausal women
8
estradiol kupperman
8

Similar Publications

Soybean isoflavone (SIF) in soybeans are natural phytoestrogens, which is functioned as an estrogen agonistic or antagonistic. SIF regulates the capacity of animals to synthesize triacylglycerols by directly utilizing long-chain fatty acids. However, few studies have focused on its regulatory lipid metabolism in lactating dairy goats.

View Article and Find Full Text PDF
Article Synopsis
  • Genistin, an isoflavone found in soybeans, was tested on 72 gestating sows to see how it affects reproductive performance and immunity by supplementing their diet with 150 mg/kg.
  • Results indicated that genistin significantly improved the number of live piglets and reduced stillbirth rates, although it also led to lighter average weights for the live-born piglets.
  • The experiment also showed that genistin increased key immune markers in the sows while potentially reducing certain cholesterol levels later in gestation, indicating it has various beneficial effects on both the sows and their litters.
View Article and Find Full Text PDF

Obesity is an important risk factor for breast cancer in women before and after menopause. Adipocytes, key mediators in the tumor microenvironment, play a pivotal role in the relationship between obesity with cancer. However, the potential of dietary components in modulating this relationship remains underexplored.

View Article and Find Full Text PDF

Microglial CR3 promotes neuron ferroptosis via NOX2-mediated iron deposition in rotenone-induced experimental models of Parkinson's disease.

Redox Biol

November 2024

School of Public Health, Dalian Medical University, No. 9 W. Lvshun South Road, Dalian, 116044, China; National-Local Joint Engineering Research Center for Drug-Research and Development (R & D) of Neurodegenerative Diseases, Dalian Medical University, No. 9 W. Lvshun South Road, Dalian, 116044, China. Electronic address:

The activation of complement receptor 3 (CR3) in microglia contributes to neurodegeneration in neurological disorders, including Parkinson's disease (PD). However, it remains unclear for mechanistic knowledge on how CR3 mediates neuronal damage. In this study, the expression of CR3 and its ligands iC3b and ICAM-1 was found to be up-regulated in the midbrain of rotenone PD mice, which was associated with elevation of iron content and disruption of balance of iron metabolism proteins.

View Article and Find Full Text PDF

Background: Sarcopenic obesity, which is associated with a poorer prognosis than that of sarcopenia alone, may be positively affected by soy isoflavones, known inhibitors of muscle atrophy. Herein, we hypothesize that these compounds may prevent sarcopenic obesity by upregulating the gut metabolites with anti-inflammatory effects.

Methods: To explore the effects of soy isoflavones on sarcopenic obesity and its mechanisms, we employed both in vivo and in vitro experiments.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!